Browsing: inc.

Jack Mason stands at the forefront of modern business leadership as the Group CEO and Co-Founder of Inc & Co. His commitment to building a collaborative business environment is revolutionising how companies grow and succeed. Through his strategic vision, Mason has transformed Inc & Co by fostering shared expertise and resources among diverse businesses, allowing them to thrive together. As an entrepreneur, Mason’s approach combines innovation with collaboration. He offers insights into the importance of creating spaces where ideas can flow easily and partnerships can flourish. Under his leadership, Inc & Co has expanded quickly, proving the power of a…

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing innovative product candidates to treat brain health disorders, today announced the pricing of an underwritten public offering of 9,285,511 common shares, without par value, at a public offering price of $7.00 per common share. Additionally, to certain investors, the Company is offering pre-funded warrants to purchase 1,428,775 common shares at a price of $6.999 per pre-funded warrant, which represents the per-share public offering price for the common shares, less the $0.001 per share exercise price for each pre-funded warrant. The gross proceeds to MindMed from…